N-acetylaspartic acid monitors oxidative stress by Surendran, Sankar
EXCLI Journal 2011;10:52-54  ISSN 1611-2156 
Received: April 18, 2011, accepted: April 28, 2011, published: May 02, 2011 
 
52 
Editorial: 
N-acetylaspartic acid monitors oxidative stress  
 
Sankar Surendran 
 
1 UNT Health Science center, Fort Worth, Texas, USA; 
Email: sankar_surendran@yahoo.com; Tel: +1 504 568 5481 
 
N-acetylaspartic acid (NAA) was discovered by Tallan et al., in 1956.  It is synthesized from 
acetyl coenzyme A and aspartate by a mitochondrial enzyme, L-aspartate N-acetyltransferase 
(Goldstein, 1969). NAA is mainly found in the gray matter of the brain and also present at 
lower levels in the astroglia, white matter, superior cervical ganglion, splenic nerve, periph-
eral nervous tissue of spleen, lung, liver, kidney, muscle, ovary, thymus, stomach, heart, adre-
nal medulla and retina of fishes to mammals (see review, Surendran et al., 2011). Normal 
level of NAA is important in the maintenance of potential antioxidants.  N-acetylaspartic acid 
level is altered in many diseases including alcoholic brain (Schweinsburg et al., 2001), brain 
oedema (Demougeot et al., 2001), HIV-related dementia (Meyerhoff et al., 1993; Sacktor et 
al., 2005), HIV positive alcoholism (Pfefferbaum et al., 2005), Canavan disease (see review, 
Surendran et al., 2011), Parkinson’s disease (Surendran and Rajasankar, 2010), type 2 diabe-
tes (Surendran et al., 2006) and spinocerebellar ataxia type 1 (Oz et al., 2010). Altered levels 
of NAA changes nitric oxide and potential antioxidant levels to cause disease pathophysiol-
ogy (Surendran, 2009; Surendran and Rajasankar, 2010), suggesting NAA monitors oxidative 
stress by regulating antioxidant levels. 
 
Aspartoacylase deacetylates N-acetylaspartic acid into aspartate and acetate (Birnbaum et al., 
1952). While aspartoacylase activity is very mild or no activity in normal astrocytes, the ac-
tivity is increased in inflammatory conditions suggesting aspartoacylase contribution in reac-
tive astrocytes (Surendran, 2007; Surendran et al., 2011). In Table 1, the key message of re-
cently published studies on NAA effect on oxidative stress has been summarized. 
 
Table 1: Studies in N-acetylaspartic acid (NAA) resulting oxidative stress 
 
Key message Reference 
 
NAA induced nitric oxide toxicity and alters proteins associated 
with inflammation, transcription and contractilty to cause patho-
physiology 
Surendran, 2009  
NAA induced nitric oxide toxicity contribute to neurodegenera-
tion 
Surendran, 2008  
NAA induced nitric oxide toxicity to cause Canavan disease 
pathophysiology 
Surendran, 2010 
Altered levels of nitric oxide cause contractile abnormality Surendran and Kondapaka, 2005 
NAA contributes in Parkinson’s disease Surendran and Rajasankar, 2010 
NAA induced oxidative stress to contribute in disease patho-
physiology 
Surendran and Bhatnagar, 2011 
NAA induced nitric oxide toxicity contributes in Canavan dis-
ease pathophysiology 
Surendran et al., 2011 
NAA reduced glucose 6-phosphate dehydrogenase and en-
hanced protein carbonyl content and superoxide dismutase 
Pederzolli et al., 2009 
NAA reduced catalase and glutathione peroxidase and induced 
hydrogen peroxide 
Pederzolli et al., 2010 
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